Search Ontology:
ChEBI

EVP4593

Term ID
CHEBI:232358
Synonyms
  • 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
  • 6-amino-4-(4-phenoxyphenylethylamino)quinazoline
  • 6-amino-4-[2-(4-phenoxyphenyl)ethylamino]quinazoline
  • AG-F-89549
  • CAY 10470
  • CAY-10470
  • CAY10470
  • EVP 4593
  • EVP-4593
  • N(4)-(4-phenoxyphenethyl)quinazoline-4,6-diamine
  • N(4)-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine
  • N(4)-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
  • QNZ
Definition
A member of the class of quinazolines that is quinazoline substituted by [2-(4-phenoxyphenyl)ethyl]amino and amino groups at positions 4 and 6, respectively. It is an inhibitor of NF-κB signal transduction pathway and exhibits protective effects in oncology, cardiovascular disease and parasite invasion.
References
  • cas:545380-34-5
  • hmdb:HMDB0246942
  • lincs.smallmolecule:LSM-45149
  • pubmed:21700213
  • pubmed:28000898
  • pubmed:28302490
  • pubmed:28693192
  • pubmed:30108783
  • pubmed:30194168
  • pubmed:30638515
  • pubmed:30704052
  • pubmed:31055008
  • pubmed:32432727
  • pubmed:34564023
  • pubmed:34722891
  • pubmed:35871734
  • pubmed:36349549
  • pubmed:36552336
  • pubmed:36555369
  • pubmed:36805135
  • pubmed:37175413
  • pubmed:37179969
  • pubmed:37256224
  • pubmed:38095503
  • pubmed:39120322
  • pubmed:39268468
  • reaxys:9350957
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from EVP4593
Phenotype where environments contain EVP4593
Phenotype modified by environments containing EVP4593
Phenotype affecting EVP4593
Human Disease Model